After a four-month investigation, Nature Medicine has decided to pull a viral study that linked early-day PD-1/chemo ...

Part C domestic enrollment is underway at three clinical sites in the U.S.CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc.

The class of drugs known as DNA Damage Response inhibitors, which work by blocking cancer cells’ ability to repair their own damaged DNA, is expanding rapidly beyond its original anchor, the PARP ...

Nothing about long Covid adds up. All of this is very strange. Stranger still are patients’ stories of astonishing recoveries ...

Researchers at the University of Pennsylvania analyzed data from 111,646 women and found that those who used GLP-1 receptor ...

Discusses V012 Study Top-Line Results for Engineered Vessel in Dialysis Access June 15, 2026 5:00 PM EDTCompany ...

Discusses Updated Long-term Data From Phase 2 BESTOW Clinical Trial in Kidney Transplantation June 22, 2026 8:00 ...

Patients with advanced squamous non-small-cell lung cancer who received the bispecific antibody ivonescimab alongside chemotherapy had a 40% lower risk of disease progression or death compared with ...

Phase I/II study can serve as the primary basis of a Biologics License Application for accelerated approval with FDA ~ ~ Company intends to submit the BLA in third quarter ...

Slim tide uses Akkermansia muciniphila and prebiotic fibers to support gut health and metabolism. Read the full 2026 slim tide ingredient and safety analysis.

Introduction Autistic children can experience elevated levels of emotional and behavioural problems, which adversely impact their psychosocial functioning. Positive parenting behaviours can ...

We break down what the data actually says about how remote work has changed since the pandemic, where it stands now and what ...